Molecular regulation of the IGF-binding protein-4 protease system in human fibroblasts: identification of a novel inducible inhibitor

Endocrinology. 2002 Apr;143(4):1199-205. doi: 10.1210/endo.143.4.8729.

Abstract

The IGF-binding protein-4 (IGFBP-4) protease system is an important regulator of local IGF bioavailability and cell growth. Recently, the IGF-dependent IGFBP-4 protease secreted by cultured human fibroblasts was identified as pregnancy-associated plasma protein A (PAPP-A). In pregnancy serum, PAPP-A circulates as a disulfide-bound complex with the precursor form of major basic protein (pro-MBP), and in this complex PAPP-A's proteolytic activity is not evident. In this study we analyzed the IGFBP-4 protease system in normal human fibroblasts to determine regulation outside of pregnancy. Treatment with the phorbol ester tumor promoter, beta-phorbol 12,13-didecanoate (beta-PDD), resulted in time-dependent inhibition of the IGF-dependent IGFBP-4 protease activity in cell-conditioned medium, which was evident at 6 h and complete by 24 h. PAPP-A mRNA was constitutively expressed in control cells, and levels were decreased only after 24 h of beta-PDD treatment. Secretion of PAPP-A protein into conditioned medium did not change with beta-PDD treatment. On the other hand, pro-MBP mRNA was undetectable in control human fibroblasts, and treatment with beta-PDD induced pro-MBP mRNA and protein expression within 6 h. beta-PDD-induced pro-MBP mRNA expression and protease inhibition were blocked with an inhibitor of RNA synthesis, actinomycin D. Actinomycin D had no effect on PAPP-A mRNA levels in the absence or presence of beta-PDD. Similarly, transformation of human fibroblasts with simian virus 40 large T antigen resulted in the synthesis of pro-MBP mRNA and protein and inhibition of IGFBP-4 protease activity. Coculture of fibroblasts with cells transfected with pro-MBP cDNA resulted in inhibition of IGFBP-4 proteolytic activity without having any effect on PAPP-A synthesis. In summary, phorbol ester tumor promoters and simian virus 40 transformation regulate IGFBP-4 proteolysis in human fibroblasts through induction of a novel inhibitor of PAPP-A, pro-MBP. These findings expand our understanding of the IGFBP-4 protease system and suggest an additional level of local cell growth control.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Proteins / biosynthesis
  • Cells, Cultured
  • Culture Media, Conditioned
  • Enzyme-Linked Immunosorbent Assay
  • Eosinophil Granule Proteins
  • Eosinophils / metabolism
  • Female
  • Fibroblasts / enzymology
  • Gene Expression Regulation, Enzymologic / genetics*
  • Humans
  • Immunoblotting
  • Metalloendopeptidases / antagonists & inhibitors*
  • Metalloendopeptidases / genetics
  • Metalloendopeptidases / metabolism*
  • Plasmids / genetics
  • Pregnancy-Associated Plasma Protein-A / genetics
  • Protease Inhibitors / metabolism*
  • RNA Probes
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / isolation & purification
  • Reverse Transcriptase Polymerase Chain Reaction
  • Ribonucleases*
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Blood Proteins
  • Culture Media, Conditioned
  • Eosinophil Granule Proteins
  • Protease Inhibitors
  • RNA Probes
  • RNA, Messenger
  • Ribonucleases
  • Metalloendopeptidases
  • Pregnancy-Associated Plasma Protein-A